Dublin, Ireland, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Helo Corp. (OTC PINK: HLOC) ("Helo" or the "Company"), a data-driven wellness technology company leading the development of wearable and other biodata gathering devices, and artificial intelligence (AI) to drive human wellness transformation, will be providing a corporate update at the Emerging Growth Conference on January 11, 2024 at 2:55 p.m., EST (https://emerginggrowth.com/emerging-growth-conference-66/).
Helo invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. This live, interactive online event will allow existing shareholders and the investment community to interact with the Company's CEO, Sean McVeigh, in real-time. An opportunity will be provided to ask questions during the event and Mr. McVeigh will do his best to get through as many of them as possible.
At the previous Emerging Growth Conference in December, Mr. McVeigh discussed Helo’s refocused strategic direction and introduction of NutraMaticTM. "NutraMatic allows us to challenge current industry players that supply the same supplements to everyone, regardless of their state of wellness, nutritional needs, or activity levels,” said Mr. McVeigh. “In addition to NutraMatic providing turnkey precision supplements to customers worldwide, our Helo AITM recommendation engine will encourage a healthier lifestyle by providing individualized and timely feedback, which supports personal wellness improvement and customer loyalty. As NutraMatic is IoT connected, user supplement consumption will be monitored to enable an auto-ship supplement subscription model. We anticipate strong demand for NutraMatic, which we expect will be available to ship in the second quarter of 2024. In the meantime, we plan to continue our international investigational study to train our Helo AI knowledge domain and provide an even more personalized solution to our customers," continued McVeigh.
Helo Corp will be presenting from 2:55 p.m. to 3:05 p.m., Eastern standard time on Thursday, January 11, 2024. Please register here to ensure you can attend the conference and receive any updates that are released, or follow this link: https://goto.webcasts.com/starthere.jsp?ei=1643634&tp_key=65e55c6a1d&sti=eg. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com.
About the Emerging Growth Conference
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services, and other major announcements to the investment community from the convenience of their office, in a time-efficient manner. The Conference focus and coverage include companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Its audience includes potentially tens of thousands of individual and institutional investors, as well as investment advisors and analysts.
About Helo Corp:
Helo Corp. (OTC:HLOC) is a data-driven wellness technology company. Helo® wearables and other smart devices are built on Helo's Life Sensing Technology®, which uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters. Helo is developing the Helo AITM platform to leverage artificial intelligence and other technologies to analyze wearer data to provide recommendations that support the adoption of healthier lifestyle choices to drive human wellness transformation.
For more information please visit helocorp.com and nutralife.ai.
The Company's disclosure statements and financial statements are available at OTC:HLOC.
About Helo AI:
Helo AITM is an innovative, easy-to-use consumer platform designed to support wellness improvement and provide AI-generated, and app-delivered personalized wellness recommendations based on individual user biodata. This biodata is generated by Helo® products featuring Life Sensing TechnologyTM, including its recently launched BioStripTM, award-winning BioSense health bandTM, and other wearables and connected wellness technology devices. NutraMaticTM is a countertop device designed to provide users with their AI-optimized and personalized combination of nutrition supplements, based on their current biodata status.
Forward Looking Statements
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expect," "anticipate," "plan," and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Investors Contact:
investors@helocorp.com
+1 650-646-2193
